نتایج جستجو برای: hdac

تعداد نتایج: 4231  

Four prenylated flavonoids including isosophoranone, sophoraflavanone G, alopecurone J, alopecurone P and a resveratrol derivative HPD (2-(4-hydroxyphenyl)-2,3-dihydrobenzo[b] furan-3,4,6-triol), were isolated from the roots of Sophora pachycarpa. The cytotoxic activity of obtained compounds was evaluated against A2780, A549, HeLa, and HCT116 human cancer cell lines. We also evaluated their his...

Journal: :genetics in the 3rd millennium 0
امید آریانی omid aryani special medical center, tehran, iran مهری عابدی mehry abedi سپیده دادگر sepideh dadgar مسعود جمالی masoud jamali

neurodegenerative disorders such as huntingtons disease, alzheimers disease, parkinsons disease, amyotrophic lateral sclerosis, spinal muscular atrophy, friedreichs ataxia, and others are multi-factorial illnesses in which many pathways (still poorly understood) act serially and in parallel to give a determined pathologic phenotype. thus, presently there are no effective cures for these disease...

Four prenylated flavonoids including isosophoranone, sophoraflavanone G, alopecurone J, alopecurone P and a resveratrol derivative HPD (2-(4-hydroxyphenyl)-2,3-dihydrobenzo[b] furan-3,4,6-triol), were isolated from the roots of Sophora pachycarpa. The cytotoxic activity of obtained compounds was evaluated against A2780, A549, HeLa, and HCT116 human cancer cell lines. We also evaluated their his...

Journal: :Blood 1996
J K Weick K J Kopecky F R Appelbaum D R Head L L Kingsbury S P Balcerzak J N Bickers H E Hynes J L Welborn S R Simon M Grever

Interest in high-dose cytarabine (HDAC) for both induction and postremission therapy for acute myeloid leukemia (AML) prompted the Southwest Oncology Group (SWOG) to initiate a randomized trial comparing HDAC with standard-dose cytarabine (SDAC) for remission induction of previously untreated AML and to compare high-dose treatment versus conventional doses for consolidation therapy. Patients le...

2014
Cédric Poyet Bastian Jentsch Thomas Hermanns Daniel Schweckendiek Hans-Helge Seifert Martin Schmidtpeter Tullio Sulser Holger Moch Peter J Wild Glen Kristiansen

BACKGROUND Histone deacetylases (HDACs) are known to be associated with an overexpression in different types of cancer such as colon and prostate cancer. In this study we aimed to evaluate the protein expression of class I HDACs in urothelial carcinoma of the bladder. METHODS A tissue microarray containing 348 tissuesamples from 174 patients with a primary urothelial carcinoma of the bladder ...

Journal: :Molecular cancer therapeutics 2006
Madhuri Sankaranarayanapillai William P Tong David S Maxwell Ashutosh Pal Jihai Pang William G Bornmann Juri G Gelovani Sabrina M Ronen

Histone deacetylase (HDAC) inhibitors are new and promising antineoplastic agents. Current methods for monitoring early response rely on invasive biopsies or indirect blood-derived markers. Our goal was to develop a magnetic resonance spectroscopy (MRS)-based method to detect HDAC inhibition. The fluorinated lysine derivative Boc-Lys-(Tfa)-OH (BLT) was investigated as a (19)F MRS molecular mark...

Journal: :Autoimmunity 2009
Yutaka Kuwatsuka Fumihide Ogawa Yohei Iwata Kazuhiro Komura Eiji Muroi Toshihide Hara Motoi Takenaka Kazuhiro Shimizu Minoru Hasegawa Manabu Fujimoto Shinichi Sato

Systemic sclerosis (SSc) is characterized by immunological abnormalities, especially the production of autoantibodies against various cellular components. Treatment with histone deacetylase (HDAC) inhibitors prevents collagen accumulation in a mouse SSc model. Additionally, autoantibody against HDAC-3 is produced in colon cancer patients, while HDAC-1 and HDAC-2 do not elicit autoantibody respo...

Journal: :Experimed 2021

Objective: Natural ingredients derived from plants (especially edible ones) continue to be investigated for understanding whether they have therapeutic/preventive effects on certain ailments, such as cancer and gastrointestinal disorders. The main goal of the current work is investigate inhibitory potential Eremurus spectabilis M. Bieb. extracts histone deacetylase (HDAC), xanthine oxidase (XO)...

2016
Jin Ho Kim Sung Ho Moon Mina No Jae Jin Kim Eun Jung Choi Bong Jun Cho Jae Sung Kim Il Han Kim In Ah Kim

PURPOSE Histone deacetylase (HDAC) inhibitors radiosensitize tumor cells. To elucidate mechanisms underlying radiosensitization by HDAC inhibition, understanding of differential contributions of HDAC isotypes is needed. The aim of this study was to investigate involvement of known HDAC isotypes in modulation of cellular radiosensitivity. MATERIALS AND METHODS Because pharmacologic HDAC inhibi...

2017
S Jaramillo A Benner J Krauter H Martin T Kindler M Bentz H R Salih G Held C-H Köhne K Götze M Lübbert A Kündgen P Brossart M Wattad H Salwender B Hertenstein D Nachbaur G Wulf H-A Horst H Kirchen W Fiedler A Raghavachar G Russ S Kremers E Koller V Runde G Heil D Weber G Göhring K Döhner A Ganser H Döhner R F Schlenk

The aim of this cohort study was to compare a condensed schedule of consolidation therapy with high-dose cytarabine on days 1, 2 and 3 (HDAC-123) with the HDAC schedule given on days 1, 3 and 5 (HDAC-135) as well as to evaluate the prophylactic use of pegfilgrastim after chemotherapy in younger patients with acute myeloid leukemia in first complete remission. One hundred and seventy-six patient...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید